225 related articles for article (PubMed ID: 8152811)
1. Transfection and expression of mutant p53 protein does not alter the in vivo or in vitro growth characteristics of the AA/C1 human adenoma derived cell line, including sensitivity to transforming growth factor-beta 1.
Williams AC; Browne SJ; Manning AM; Daffada P; Collard TJ; Paraskeva C
Oncogene; 1994 May; 9(5):1479-85. PubMed ID: 8152811
[TBL] [Abstract][Full Text] [Related]
2. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF-beta): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-beta.
Manning AM; Williams AC; Game SM; Paraskeva C
Oncogene; 1991 Aug; 6(8):1471-6. PubMed ID: 1886718
[TBL] [Abstract][Full Text] [Related]
3. Neoplastic transformation of a human colonic epithelial cell line: in vitro evidence for the adenoma to carcinoma sequence.
Williams AC; Harper SJ; Paraskeva C
Cancer Res; 1990 Aug; 50(15):4724-30. PubMed ID: 2369746
[TBL] [Abstract][Full Text] [Related]
4. Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma.
Williams AC; Browne SJ; Yeudal WA; Paterson IC; Marshall CJ; Lane DP; Paraskeva C
Oncogene; 1993 Nov; 8(11):3063-72. PubMed ID: 8414507
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.
Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E
Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169
[TBL] [Abstract][Full Text] [Related]
6. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK
Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532
[TBL] [Abstract][Full Text] [Related]
7. An acidic environment leads to p53 dependent induction of apoptosis in human adenoma and carcinoma cell lines: implications for clonal selection during colorectal carcinogenesis.
Williams AC; Collard TJ; Paraskeva C
Oncogene; 1999 May; 18(21):3199-204. PubMed ID: 10359525
[TBL] [Abstract][Full Text] [Related]
8. Interaction between p53 and TGF beta 1 in control of epithelial cell proliferation.
Blaydes JP; Schlumberger M; Wynford-Thomas D; Wyllie FS
Oncogene; 1995 Jan; 10(2):307-17. PubMed ID: 7838530
[TBL] [Abstract][Full Text] [Related]
9. Mutant p53 tumor suppressor gene causes resistance to transforming growth factor beta 1 in murine keratinocytes.
Reiss M; Vellucci VF; Zhou ZL
Cancer Res; 1993 Feb; 53(4):899-904. PubMed ID: 8094035
[TBL] [Abstract][Full Text] [Related]
10. Reduction of TGF-beta activity abrogates growth promoting tumor cell-cell interactions in vivo.
Theodorescu D; Caltabiano M; Greig R; Rieman D; Kerbel RS
J Cell Physiol; 1991 Sep; 148(3):380-90. PubMed ID: 1655815
[TBL] [Abstract][Full Text] [Related]
11. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line].
Wang H; Lai B; Li J
Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):268-72. PubMed ID: 11326947
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line.
Okamoto M; Oyasu R
Cell Growth Differ; 1997 Aug; 8(8):921-6. PubMed ID: 9269901
[TBL] [Abstract][Full Text] [Related]
13. Mutant p53 is not fully dominant over endogenous wild type p53 in a colorectal adenoma cell line as demonstrated by induction of MDM2 protein and retention of a p53 dependent G1 arrest after gamma irradiation.
Williams AC; Miller JC; Collard TJ; Bracey TS; Cosulich S; Paraskeva C
Oncogene; 1995 Jul; 11(1):141-9. PubMed ID: 7624121
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of radiation-induced G2 delay potentiates cell death by apoptosis and/or the induction of giant cells in colorectal tumor cells with disrupted p53 function.
Bracey TS; Williams AC; Paraskeva C
Clin Cancer Res; 1997 Aug; 3(8):1371-81. PubMed ID: 9815821
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line.
Fink SP; Swinler SE; Lutterbaugh JD; Massagué J; Thiagalingam S; Kinzler KW; Vogelstein B; Willson JK; Markowitz S
Cancer Res; 2001 Jan; 61(1):256-60. PubMed ID: 11196171
[TBL] [Abstract][Full Text] [Related]
17. Clonal variation of p53 expression and proliferative phenotype in A253 squamous carcinoma cells.
Galbraith SC; Foley J; Kats Y; Moy A; Dann P; Burtis WJ; Philbrick WM; Orloff JJ
Oncol Res; 1996; 8(9):353-61. PubMed ID: 8979269
[TBL] [Abstract][Full Text] [Related]
18. Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation.
Rowland-Goldsmith MA; Maruyama H; Kusama T; Ralli S; Korc M
Clin Cancer Res; 2001 Sep; 7(9):2931-40. PubMed ID: 11555612
[TBL] [Abstract][Full Text] [Related]
19. Loss of growth control by TGF-beta occurs at a late stage of mouse skin carcinogenesis and is independent of ras gene activation.
Haddow S; Fowlis DJ; Parkinson K; Akhurst RJ; Balmain A
Oncogene; 1991 Aug; 6(8):1465-70. PubMed ID: 1886717
[TBL] [Abstract][Full Text] [Related]
20. Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence.
Chell SD; Witherden IR; Dobson RR; Moorghen M; Herman AA; Qualtrough D; Williams AC; Paraskeva C
Cancer Res; 2006 Mar; 66(6):3106-13. PubMed ID: 16540660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]